In humans, SOST mutations are associated with conditions characterized by excess bone formation: sclerosteosis, van Buchem disease, craniodiaphyseal dysplasia and the HBM phenotype (Table 1 and Figure 4). This evidence concerns the gene SOST and sclerosteosis.